Results of CBL0137 Clinical Trials Will Be Presented at the ASCO Annual Meeting 2020

  • 08.05.2020

The results of two completed clinical trials of the curaxin CBL0137 (oral and intravenous administration) in patients with advanced solid tumors will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2020 during the Poster Session: Developmental Therapeutics – Molecularly Targeted Agents and Tumor Biology (posters #337 and #313). Join us on May 29, 2020, at the virtual meeting.